Godavari Drugs Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 386.67 million compared to INR 309.2 million a year ago. Revenue was INR 387.57 million compared to INR 311.25 million a year ago. Net income was INR 12.21 million compared to INR 9.88 million a year ago. Basic earnings per share from continuing operations was INR 1.62 compared to INR 1.31 a year ago. Diluted earnings per share from continuing operations was INR 1.62 compared to INR 1.31 a year ago. For the six months, sales was INR 830.69 million compared to INR 566.13 million a year ago. Revenue was INR 831.76 million compared to INR 568.27 million a year ago. Net income was INR 26.46 million compared to INR 18.39 million a year ago. Basic earnings per share from continuing operations was INR 3.51 compared to INR 2.44 a year ago. Diluted earnings per share from continuing operations was INR 3.51 compared to INR 2.44 a year ago.